First Trust Exchange-Traded Fund VI (FTXH)
Management Company · XNAS · Series S000053945 · View on SEC EDGAR ↗
$34.57
As of March 10, 2026
▼ -0.01 (-0.02%)
1-day change
$23.29 – $35.57
52-week range
Holdings data is not available for this fund yet.
On this page
- Price chart The fund's market price over time, with technical overlays.
- Performance Total return, volatility, drawdown and other risk metrics.
- Fund flows Money flowing in and out of the fund each month, from N-PORT filings.
- Holdings Every position the fund currently holds, with weights.
- Institutional owners 13F institutions that report holding this ETF.
- Similar funds Other funds with overlapping holdings or comparable size.
FTXH Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
Performance as of March 10, 2026
| Period | Price return | Total return |
|---|---|---|
| 1M | ▼ -0.57% | — |
| 3M | ▲ +6.94% | — |
| 6M | ▲ +23.72% | — |
| YTD | ▲ +4.95% | — |
| 1Y | ▲ +20.39% | — |
| 3Y | — | — |
| 5Y | — | — |
| Max since Feb. 27, 2024 | ▲ +21.99% | — |
- Volatility 1Y
- 20.83%
- Volatility 3Y
- —
- Max drawdown 3Y
- —
- Beta 3Y
- —
- Sharpe 1Y*
- 1.01
Total return is shown once dividend history for this fund has been collected — price return alone would duplicate it misleadingly. Returns are not benchmarked against an index. * Sharpe ratio is computed with a 0% risk-free rate.
Fund flows (SEC-reported)
- Last month (Mar 2026)
- +$0
- Quarter ending Mar 2026
- +$6.9M
- Trailing 12 months
- +$9.8M
Apr 2025 – Mar 2026
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 51 holdings
| Name | CUSIP | Value | % | Balance | Category | Country |
|---|---|---|---|---|---|---|
| Johnson & Johnson | 478160104 | $2.2M | 7.45 | 8,893 | EC | US |
| Bristol-Myers Squibb Company | 110122108 | $2.1M | 7.36 | 35,422 | EC | US |
| Merck & Co., Inc | 58933Y105 | $2.1M | 7.36 | 17,843 | EC | US |
| AbbVie Inc. | 00287Y109 | $2.1M | 7.10 | 9,520 | EC | US |
| Eli Lilly & Co. | 532457108 | $1.9M | 6.62 | 2,100 | EC | US |
| Pfizer Inc. | 717081103 | $1.1M | 3.85 | 39,951 | EC | US |
| Regeneron Pharmaceuticals, Inc. | 75886F107 | $1.1M | 3.74 | 1,413 | EC | US |
| Biogen Inc | 09062X103 | $1.1M | 3.62 | 5,759 | EC | US |
| Gilead Sciences Inc. | 375558103 | $1.0M | 3.54 | 7,416 | EC | US |
| Cardinal Health, Inc. | 14149Y108 | $1.0M | 3.49 | 4,819 | EC | US |
| Amgen Inc. | 031162100 | $1.0M | 3.43 | 2,846 | EC | US |
| Viatris Inc | 92556V106 | $1000K | 3.43 | 73,989 | EC | US |
| Zoetis Inc. | 98978V103 | $996K | 3.41 | 8,426 | EC | US |
| Vertex Pharmaceuticals Incorporated | 92532F100 | $993K | 3.40 | 2,223 | EC | US |
| United Therapeutics Corporation | 91307C102 | $967K | 3.31 | 1,630 | EC | US |
| Incyte Corporation. | 45337C102 | $644K | 2.21 | 6,843 | EC | US |
| Jazz Pharmaceuticals PLC | — | $633K | 2.17 | 3,347 | EC | IE |
| Illumina Inc | 452327109 | $451K | 1.55 | 3,657 | EC | US |
| Exelixis, Inc. | 30161Q104 | $441K | 1.51 | 10,279 | EC | US |
| Medpace Holdings Inc. | 58506Q109 | $415K | 1.42 | 865 | EC | US |
| PTC Therapeutics, Inc. | 69366J200 | $371K | 1.27 | 5,449 | EC | US |
| Charles River Laboratories International, Inc. | 159864107 | $367K | 1.26 | 2,127 | EC | US |
| Biomarin Pharmaceutical Inc. | 09061G101 | $357K | 1.22 | 6,318 | EC | US |
| Neurocrine Biosciences Inc | 64125C109 | $346K | 1.19 | 2,630 | EC | US |
| Halozyme Therapeutics Inc | 40637H109 | $323K | 1.11 | 5,005 | EC | US |
| Alkermes PLC | — | $296K | 1.02 | 8,380 | EC | IE |
| Elanco Animal Health Inc | 28414H103 | $261K | 0.90 | 10,925 | EC | US |
| Spyre Therapeutics Inc | 00773J202 | $178K | 0.61 | 3,533 | EC | US |
| Protagonist Therapeutics Inc | 74366E102 | $174K | 0.60 | 1,650 | EC | US |
| TG Therapeutics Inc | 88322Q108 | $168K | 0.57 | 5,049 | EC | US |
| Arrowhead Pharmaceuticals Inc | 04280A100 | $164K | 0.56 | 2,611 | EC | US |
| Catalyst Pharmaceuticals Inc. | 14888U101 | $163K | 0.56 | 6,583 | EC | US |
| Amneal Pharmaceuticals Inc | 03168L105 | $161K | 0.55 | 12,984 | EC | US |
| ARCUS BIOSCIENCES INC | 03969F109 | $161K | 0.55 | 7,459 | EC | US |
| Twist Bioscience Corporation | 90184D100 | $154K | 0.53 | 3,238 | EC | US |
| Ligand Pharmaceuticals Incorporated | 53220K504 | $153K | 0.52 | 766 | EC | US |
| Mirum Pharmaceuticals Inc. | 604749101 | $152K | 0.52 | 1,646 | EC | US |
| Travere Therapeutics Inc | 89422G107 | $152K | 0.52 | 5,100 | EC | US |
| Alnylam Pharmaceuticals Inc. | 02043Q107 | $151K | 0.52 | 456 | EC | US |
| Guardant Health Inc | 40131M109 | $149K | 0.51 | 1,618 | EC | US |
| Roivant Sciences Ltd | — | $145K | 0.50 | 5,250 | EC | BM |
| Moderna Inc | 60770K107 | $144K | 0.49 | 2,836 | EC | US |
| Supernus Pharmaceuticals, Inc | 868459108 | $143K | 0.49 | 2,776 | EC | US |
| Krystal Biotech Inc | 501147102 | $142K | 0.49 | 551 | EC | US |
| Tarsus Pharmaceuticals Inc | 87650L103 | $141K | 0.48 | 2,012 | EC | US |
| Ionis Pharmaceuticals, Inc. | 462222100 | $141K | 0.48 | 1,872 | EC | US |
| 10X Genomics Inc | 88025U109 | $140K | 0.48 | 6,591 | EC | US |
| Kymera Therapeutics Inc | 501575104 | $139K | 0.47 | 1,663 | EC | US |
| Acadia Pharmaceuticals Inc | 004225108 | $138K | 0.47 | 6,186 | EC | US |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | $133K | 0.45 | 5,633 | EC | US |
Page 1
of 2
← Previous
Next →
Institutional owners (13F) 31 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| LPL Financial LLC | $5,784,616 | 27.94% | 151,471 | Shares | June 30, 2026 |
| OPPENHEIMER & CO INC | $4,360,615 | 21.06% | 114,183 | Shares | June 30, 2026 |
| TRUIST FINANCIAL CORP | $1,990,662 | 9.61% | 52,126 | Shares | June 30, 2026 |
| MARSHALL INVESTMENT MANAGEMENT, LLC | $1,454,249 | 7.02% | 38,080 | Shares | June 30, 2026 |
| Ameritas Investment Partners, Inc. | $1,297,935 | 6.27% | 33,987 | Shares | June 30, 2026 |
| Nilsine Partners, LLC | $1,071,488 | 5.18% | 28,057 | Shares | June 30, 2026 |
| GOLDMAN SACHS GROUP INC | $524,345 | 2.53% | 13,730 | Shares | June 30, 2026 |
| ROYAL BANK OF CANADA | $513,000 | 2.48% | 13,425 | Shares | June 30, 2026 |
| DEBUSSY CAPITAL MANAGEMENT LP | $432,560 | 2.09% | 12,590 | Shares | March 31, 2026 |
| COMMONWEALTH EQUITY SERVICES, LLC | $409,910 | 1.98% | 10,734 | Shares | June 30, 2026 |
| OneDigital Investment Advisors LLC | $356,119 | 1.72% | 9,325 | Shares | June 30, 2026 |
| RAYMOND JAMES FINANCIAL INC | $330,799 | 1.60% | 8,662 | Shares | June 30, 2026 |
| Sound Income Strategies, LLC | $329,463 | 1.59% | 8,627 | Shares | June 30, 2026 |
| ENVESTNET ASSET MANAGEMENT INC | $318,504 | 1.54% | 8,340 | Shares | June 30, 2026 |
| Stratos Wealth Partners, LTD. | $312,392 | 1.51% | 8,180 | Shares | June 30, 2026 |
| CITADEL ADVISORS LLC | $260,530 | 1.26% | 6,822 | Shares | June 30, 2026 |
| BETO FINANCIAL GROUP, LLC | $259,848 | 1.26% | 6,833 | Shares | June 30, 2026 |
| FLAGSHIP HARBOR ADVISORS, LLC | $215,085 | 1.04% | 5,632 | Shares | June 30, 2026 |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | $168,499 | 0.81% | 4,421 | Shares | June 30, 2026 |
| OSAIC HOLDINGS, INC. | $91,444 | 0.44% | 2,394 | Shares | June 30, 2026 |
| LANARK FINANCIAL, INC. | $44,376 | 0.21% | 1,162 | Shares | June 30, 2026 |
| Steward Partners Investment Advisory, LLC | $39,946 | 0.19% | 1,046 | Shares | June 30, 2026 |
| BANK OF MONTREAL /CAN/ | $37,922 | 0.18% | 993 | Shares | June 30, 2026 |
| HARBOUR INVESTMENTS, INC. | $35,478 | 0.17% | 929 | Shares | June 30, 2026 |
| Asset Dedication, LLC | $22,647 | 0.11% | 593 | Shares | June 30, 2026 |
| Integrated Wealth Concepts LLC | $17,186 | 0.08% | 450 | Shares | June 30, 2026 |
| Capital Investment Advisory Services, LLC | $17,185 | 0.08% | 450 | Shares | June 30, 2026 |
| Princeton Global Asset Management LLC | $5,728 | 0.03% | 150 | Shares | June 30, 2026 |
| Cambridge Investment Research Advisors, Inc. | $1,166 | 0.01% | 30,525 | Shares | June 30, 2026 |
| MORGAN STANLEY | $92 | 0.00% | 2 | Shares | June 30, 2026 |
| WELLS FARGO & COMPANY/MN | $52 | 0.00% | 1 | Shares | June 30, 2026 |
Peer funds
More from this issuer
| Fund | AUM |
|---|---|
| BUFR First Trust Exchange-Traded Fun… | $9.6B |
| FTSM First Trust Exchange-Traded Fun… | $6.4B |
| FPE First Trust Exchange-Traded Fun… | $6.4B |
| LMBS First Trust Exchange-Traded Fun… | $6.2B |
| EMLP First Trust Exchange-Traded Fun… | $4.1B |
| KNG First Trust Exchange-Traded Fun… | $3.4B |
| FIXD First Trust Exchange-Traded Fun… | $3.3B |
| UCON First Trust Exchange-Traded Fun… | $3.3B |
| RDVI First Trust Exchange-Traded Fun… | $3.1B |
| FTCB First Trust Exchange-Traded Fun… | $2.4B |
Similar by size
| Fund | AUM |
|---|---|
| QNXT iShares Trust | $29.2M |
| EBIZ Global X Funds | $29.2M |
| MLPD Global X Funds | $29.4M |
| JADE J.P. Morgan Exchange-Traded Fun… | $29.4M |
| DECP PGIM Rock ETF Trust | $29.4M |
| PBAP PGIM Rock ETF Trust | $29.0M |
| BITS Global X Funds | $29.0M |
| PBNV PGIM Rock ETF Trust | $28.8M |
| PSET Principal Exchange-Traded Funds | $28.8M |
| FLOW Global X Funds | $28.6M |